DB12257InvestigationalSmall molecule
Platinum is under investigation for the treatment of Metastatic Breast Cancer, Non-small Cell Lung Cancer, Gastric Large Cell Neuroendocrine Carcinoma, Colorectal Large Cell Neuroendocrine Carcinoma, and Pancreatic Large Cell Neuroendocrine... Platinum has been investigated for the treatment and supportive care of Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Primary Cancer, Non Small Cell Lung Cancer, and Primary Peritoneal Carcinoma, among others.
- Formula / weight
- Pt · 195.084 g/mol (avg)
Resolves to
Clinical / RWD
Structure
InChIKey
BASFCYQUMIYNBI-UHFFFAOYSA-NSMILES[Pt]What you can answer from here — as of April 02, 2025
Which companies are running trials of Platinum, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account